| 5016 |
JX Nippon Mining & Metals Corporation
|
Strategy |
|
Notice Regarding Additional Capital Expenditure for Increased Production of Crystalline Materials (Acquisition of Fixed Assets)
|
Feb 10, 2026
|
| 5016 |
JX Nippon Mining & Metals Corporation
|
Earnings |
|
FY2026 Q3 Financial Results Presentation
|
Feb 10, 2026
|
| 5016 |
JX Nippon Mining & Metals Corporation
|
Earnings |
|
Notice Regarding Revision of Full-Year Earnings Forecast and Dividend Forecast
|
Feb 10, 2026
|
| 5016 |
JX Metals Corporation
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary〔IFRS〕(Consolidated)
|
Feb 10, 2026
|
| 4967 |
Kobayashi Pharmaceutical Co., Ltd.
|
Other |
|
Notice Regarding the Board of Directors’ Opinion on Shareholder Proposals
|
Feb 10, 2026
|
| 4967 |
Kobayashi Pharmaceutical Co., Ltd.
|
Personnel |
|
Notice Regarding Executive Personnel Changes Following Transition to a Company with an Audit and Supervisory Committee
|
Feb 10, 2026
|
| 4967 |
Kobayashi Pharmaceutical Co., Ltd.
|
M&A |
|
Notice Regarding Transition to a Company with an Audit and Supervisory Committee
|
Feb 10, 2026
|
| 4967 |
Kobayashi Pharmaceutical Co., Ltd.
|
Other |
|
Notice on Progress of Recurrence Prevention Measures
|
Feb 10, 2026
|
| 4967 |
Kobayashi Pharmaceutical Co., Ltd.
|
Strategy |
|
Notice Regarding the Formulation of Medium-Term Management Plan (2026-2028)
|
Feb 10, 2026
|
| 4967 |
Kobayashi Pharmaceutical Co., Ltd.
|
Earnings |
|
Financial Summary for the Fiscal Year Ending December 2025 [Japanese GAAP] (Consolidated)
|
Feb 10, 2026
|
| 4931 |
Shinnihonseiyaku Co., Ltd.
|
Earnings |
|
Supplementary Explanation Materials for Q1 FY2026 Earnings
|
Feb 10, 2026
|
| 4931 |
Shinnihonseiyaku Co., Ltd.
|
Earnings |
|
Fiscal Year Ending September 2026 1st Quarter Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 10, 2026
|
| 4911 |
Shiseido Company, Limited
|
Dividend |
|
Notice Regarding Receipt of Dividends from Consolidated Subsidiary
|
Feb 10, 2026
|
| 4911 |
Shiseido Company, Limited
|
Earnings |
|
Notice Regarding Recording of Equity Method Investment Valuation Loss in the 2025 December Term Individual Financial Summary
|
Feb 10, 2026
|
| 4911 |
Shiseido Company, Limited
|
Earnings |
|
Notice Regarding the Differences Between Full-Year Consolidated Earnings Guidance and Actual Results for the Fiscal Year Ending December 2025
|
Feb 10, 2026
|
| 4911 |
Shiseido Company, Limited
|
Earnings |
|
Financial Summary for the Fiscal Year Ending December 2025 [IFRS] (Consolidated)
|
Feb 10, 2026
|
| 4776 |
Cybozu, Inc.
|
Earnings |
|
Notice Regarding the Occurrence of Extraordinary Loss (Non-Consolidated Financial Results)
|
Feb 10, 2026
|
| 4755 |
Rakuten Group, Inc.
|
Earnings |
|
Notice Regarding Recognition of Impairment Loss and Derivative Valuation Gain
|
Feb 10, 2026
|
| 4628 |
SK Kaken Co., Ltd.
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 10, 2026
|
| 4464 |
Soft99 Corporation
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 10, 2026
|
